Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Aug 19;14(8):1030.
doi: 10.3390/biom14081030.

Extracellular Vesicles Induce Nuclear Factor-κB Activation and Interleukin-8 Synthesis through miRNA-191-5p Contributing to Inflammatory Processes: Potential Implications in the Pathogenesis of Chronic Obstructive Pulmonary Disease

Affiliations

Extracellular Vesicles Induce Nuclear Factor-κB Activation and Interleukin-8 Synthesis through miRNA-191-5p Contributing to Inflammatory Processes: Potential Implications in the Pathogenesis of Chronic Obstructive Pulmonary Disease

Sara Carpi et al. Biomolecules. .

Abstract

Extracellular vesicles (EVs) play a pivotal role in a variety of physiologically relevant processes, including lung inflammation. Recent attention has been directed toward EV-derived microRNAs (miRNAs), such as miR-191-5p, particularly in the context of inflammation. Here, we investigated the impact of miR-191-5p-enriched EVs on the activation of NF-κB and the expression of molecules associated with inflammation such as interleukin-8 (IL-8). To this aim, cells of bronchial epithelial origin, 16HBE, were transfected with miR-191-5p mimic and inhibitor and subsequently subjected to stimulations to generate EVs. Then, bronchial epithelial cells were exposed to the obtained EVs to evaluate the activation of NF-κB and IL-8 levels. Additionally, we conducted a preliminary investigation to analyze the expression profiles of miR-191-5p in EVs isolated from the plasma of patients diagnosed with chronic obstructive pulmonary disease (COPD). Our initial findings revealed two significant observations. First, the exposure of bronchial epithelial cells to miR-191-5p-enriched EVs activated the NF-kB signaling and increased the synthesis of IL-8. Second, we discovered the presence of miR-191-5p in peripheral blood-derived EVs from COPD patients and noted a correlation between miR-191-5p levels and inflammatory and functional parameters. Collectively, these data corroborate and further expand the proinflammatory role of EVs, with a specific emphasis on miR-191-5p as a key cargo involved in this process. Consequently, we propose a model in which miR-191-5p, carried by EVs, plays a role in airway inflammation and may contribute to the pathogenesis of COPD.

Keywords: DLCO; chronic obstructive pulmonary disease; extracellular vesicles; inflammation; interleukin-6; interleukin-8; microRNA-191; nuclear factor-κB.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

Figure 1
Figure 1
Graphical overview of the experimental design. Bronchial epithelial cells (16HBE) were transfected with miR-191-5p mimic or inhibitor. Subsequently, supernatants were collected for EV isolation and miR-191-5p quantification. Additionally, cells were harvested for miRNA extraction. The bronchial epithelial cells were then exposed to EVs (EVm: EV derived from 16HBE transfected with miR-191-5p mimic; EVi: EV derived from 16HBE transfected with miR-191-5p inhibitor; EVc: EV derived from 16HBE transfected with miRNA scramble; EVnt: EV derived from 16HBE not transfected) and subsequently collected for miR-191-5p quantification, NF-kκb activation and IL-8 evaluation. The figure was created through “biorender.com” website license agreement number EX2679WEP4, access date 11 December 2024.
Figure 2
Figure 2
Expression of miR-191-5p in 16HBE cells (A) and in EVs (B) after transfection with miRNA mimic of miR-191-5p (mimic-miR-191-5p) and miR-191-5p inhibitor (inhibitor -miR-191-5p). The mimic scramble was used as control (Ctrl) in each experiment. Non-transfected cells represent the not-treated group (Untreated). Expression of miR-191-5p in 16HBE cells (C) after incubation with EVs shed from bronchial epithelial cells transfected with mimic-miR-191-5p and inhibitor-miR-191-5p (EVm: EV derived from 16HBE transfected with miR-191-5p mimic; EVi: EV derived from 16HBE transfected with miR-191-5p inhibitor; EVc: EV derived from 16HBE transfected with miRNA scramble; EVnt: EV derived from 16HBE not transfected). Statistical analysis was performed using one-way ANOVA followed by Bonferroni’s test selected data (* p < 0.05 vs. Ctrl).
Figure 3
Figure 3
Modulation of NF-κB and IL-8 by miR-191-5p-enirched EVs. (A) Activation of NF-κB in 16HBE cells exposed to EV derived from Ach-stimulated 16HBE cells treated as described in Figure 3A (EVm: EV derived from 16HBE transfected with miR-191-5p mimic; EVi: EV derived from 16HBE transfected with miR-191-5p inhibitor; EVc: EV derived from 16HBE transfected with miRNA scramble; EVnt: EV derived from 16HBE not transfected). Then, nuclear proteins were extracted and assessed by ELISA to measure the DNA-binding activity of the p65 NF-κB subunit. (B) IL-8 secretion by 16HBE cells incubated with EVs derived from Ach-stimulated 16HBE cells, treated as described in Figure 3A. Statistical analysis was performed using one-way ANOVA followed by Tukey’s multiple comparison test (*** p < 0.001 vs. 16HBE + EVc).
Figure 4
Figure 4
Correlation of EV-derived miR-191-5p and clinical parameters. Correlation analysis was performed to assess the relationships between EV-derived miR-191-5p levels and specific clinical parameters, including IL-6 (A) and DLCO (B). For technical reasons, IL-6 level was not available in one patient. The analysis was conducted using simple linear regression analysis.
Figure 5
Figure 5
Predictive-network-based analysis involving the activation of NF-κB (A), IL-6 (B), and IL-8 (C). The modulation of the three targets predicted a positive correlation with miR-191-5p, as well as with other nodes related to disease, including IL-1, CRP, and TNF-α, among others. The bioinformatic survey pinpointed a signaling pathway consistent with expression results and reconstructed the molecular neighborhood around targets with several connection nodes that are valuable for a more comprehensive evaluation of the role of miR-191-5p in the pathogenesis of COPD.
Figure 6
Figure 6
Overview of the study main findings. The figure was created through “biorender.com” website license agreement number HP2679WJTA, access date 11 December 2024.

Similar articles

Cited by

References

    1. Agustí A., Celli B.R., Criner G.J., Halpin D., Anzueto A., Barnes P., Bourbeau J., Han M.K., Martinez F.J., Montes de Oca M., et al. Global Initiative for Chronic Obstructive Lung Disease 2023 Report: GOLD Executive Summary. Eur. Respir. J. 2023;61:2300239. doi: 10.1183/13993003.00239-2023. - DOI - PMC - PubMed
    1. Quaderi S.A., Hurst J.R. The unmet global burden of COPD. Glob. Health Epidemiol. Genom. 2018;3:e4. doi: 10.1017/gheg.2018.1. - DOI - PMC - PubMed
    1. Barnes P.J., Burney P.G., Silverman E.K., Celli B.R., Vestbo J., Wedzicha J.A., Wouters E.F. Chronic obstructive pulmonary disease. Nat. Rev. Dis. Primers. 2015;1:15076. doi: 10.1038/nrdp.2015.76. - DOI - PubMed
    1. Terry P.D., Dhand R. The 2023 GOLD Report: Updated Guidelines for Inhaled Pharmacological Therapy in Patients with Stable COPD. Pulm. Ther. 2023;9:345–357. doi: 10.1007/s41030-023-00233-z. - DOI - PMC - PubMed
    1. Papaioannou A.I., Hillas G., Loukides S., Vassilakopoulos T. Mortality prevention as the centre of COPD management. ERJ Open Res. 2024;10:00850–02023. doi: 10.1183/23120541.00850-2023. - DOI - PMC - PubMed

MeSH terms

LinkOut - more resources